| Date |
Topic |
Text |
Instructor |
| 09/01 |
Introduction
Defining Mental Illlness |
Ch 1-3 & 7 |
Langfitt |
| Unit 1: Basic Concepts of Neurotransmitter Function |
| 09/06 |
Labor Day: No Class |
|
|
| 09/08 |
Chemical Messenger Systems
|
pp. 75-86 & review basic brain organization pp. 41-75
*Deutch & Roth 2009 |
Kellogg |
| 09/13 |
Mechanisms Mediating Transmitter Effects
Transduction |
*Girault & Greengard 2009 |
Kellogg |
| 09/15 |
Mechanisms of Neural Plasticity |
Ch 5
*Nestler & Hyman 2009; *Hyman & Nestler 2009; *McGill & Zoghbi 2009 |
Kellogg |
| 09/20 |
Hormone: Brain Interactions & Stress-Responsive Neural Mechanisms |
*McEwen 2006; *Bear, Connors, & Paradiso |
Kellogg |
| Unit 2: Neurobiology of Psychoses |
| 09/22 |
The Major Psychoses |
Ch 8, pp. 186-197
*First 2009 |
Langfitt |
| 09/27 |
Neurobiology of Psychoses
Take-home Problem Set Due |
pp. 197-210
*Lewis & Volk 2009; *Abi-Dargham 2009 |
Kellogg |
| 09/29 |
Clinical Management of Psychoses |
pp. 210-214
*Tamminga 2009 |
Langfitt |
| Unit 3: Mood Disorders |
| 10/04 |
Neurobiology of Mood Disorders |
Ch 9, pp. 234-246
*Catapano 2009; *Duman 2009 |
Kellogg |
| 10/06 |
Classification of Mood Disorders |
Ch 9, pp. 215-234
*Ghaemi & Goodwin 2009 |
Langfitt |
| 10/11 |
Fall Break: No Class |
|
|
| 10/13 |
Clinical Management of Mood Disorders |
Ch 9, pp. 246-252
*Berman et al. 2009 |
Langfitt |
| Unit 4: Anxiety Disorders |
| 10/18 |
Neurobiology of Anxiety Disorders |
*McEwen 2009; *Garakani et al. 2009 |
Kellogg |
| 10/20 |
Classification of Anxiety Disorders
Take-home Exam Over Units 2 & 3 Due |
Ch 11
*Stein & Bienvenu 2009 |
Langfitt |
| 10/25 |
Clinical Management of Anxiety Disorders |
pp. 311-314
*Mathew et al. 2009 |
Langfitt |
| Unit 5: Substance Abuse |
| 10/27 |
Neural Basis of Addiction |
*Nestler 2009; *Wise 2000; *O'Brien & Dackis 2009 |
Kellogg |
| 11/01 |
Drug Abuse & the Developing Brain |
*Rubenstein & Anderson 2009; *Lester & Kosofsky 2009 |
Kellogg |
| 11/03 |
In-Class Exam Over Units 4 & 5 |
|
|
| Unit 6: Neurodegenerative Disorders |
| 11/08 |
Neural Mechanisms of Cell Death |
*Mattson 2006 |
Kellogg |
| 11/10 |
Clinical Description (and Management) of Basal Ganglia Disorders |
*Walker 2007; *Goetz 1995, pgs. 26-36; *Goetz 1995, pgs. 62-80 |
Langfitt |
| 11/15 |
Neuropathology of Basal Ganglia & Cortical Degenerative Disorders |
*Liu, Gao, & Hong 2003; *Wichmann & DeLong 2006; *Imarisio et al. 2008; *Wong, Li, & Price 2006 |
Kellogg |
| 11/17 |
Clinical Description & Management of Cortical Degenerative Disorders |
Ch 10
*Kaufer & DeKosk 2009 |
Langfitt |
| 11/22 |
In-Class Exam Over Unit 6 |
|
|
| 11/24 |
No Class: Thanksgiving Recess |
|
|
| Unit 7: Concluding Issues to Consider |
| 11/29 |
Issues of Genetic Risk |
*Hayden 2000; *Hall & Rich 2000 |
Langfitt |
| 12/01 |
Epilepsy: A Model Neuropsychiatric Syndrome? |
*Guerrini 2006; *Hermann & Whitman 1991; *Joels 2009 |
Langfitt |
| 12/06 |
Sex-related Neurobiology & Risk |
*Morris, Jordan, & Breedlove 2004; *Cahill 2005; *DeVries 2004 |
Kellogg |
| 12/08 |
Development & Evaluation of Treatments |
*Williams & Wilkins 1998; *Zubieta & Stohler 2009; *Institute of Medicine 2009 |
Langfitt |
| 12/13 |
Contribution of Functional Imaging to Understanding Mental Disorders
Take-Home Final Handed Out |
*Gur & Gur 1995; *Huetel Ch 13 |
Langfitt |
| 12/20 |
Take-Home Final Exam Due by 4:00 PM |
|
|